Risedronate Delayed-Release Tablets and Ustekinumab Intravenous Infusion
Determining the interaction of Risedronate Delayed-Release Tablets and Ustekinumab Intravenous Infusion and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: risedronate
Brand name: Actonel, Atelvia
Synonyms: Risedronate
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Risedronate Delayed-Release Tablets-Ustekinumab Subcutaneous
- Risedronate Delayed-Release Tablets-Ustekinumab Subcutaneous Injection
- Risedronate Delayed-Release Tablets-Ustell
- Risedronate Delayed-Release Tablets-UTA
- Risedronate Delayed-Release Tablets-UTA Capsules
- Risedronate Delayed-Release Tablets-UTAC tablets
- Ustekinumab Intravenous Infusion-Risedronate Sodium
- Ustekinumab Intravenous Infusion-Risedronate Tablets
- Ustekinumab Intravenous Infusion-Risperdal
- Ustekinumab Intravenous Infusion-Risperdal (Risperidone Oral Solution)
- Ustekinumab Intravenous Infusion-Risperdal (Risperidone Tablets)
- Ustekinumab Intravenous Infusion-Risperdal Consta